We serve Chemical Name:8-CHLORO-2-NAPHTHALENOL CAS:29921-50-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:8-CHLORO-2-NAPHTHALENOL
CAS.NO:29921-50-4
Synonyms:8-Chlor-2-hydroxy-naphthalin;8-Chlor-[2]naphthol;8-Chloro-2-Naphthalenol;8-chloro-2-naphthol;8-Chloro-2-hydroxynaphthalene
Molecular Formula:C10H7ClO
Molecular Weight:178.61500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.23000
Exact Mass:178.01900
LogP:3.19880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 8-Chlor-2-hydroxy-naphthalin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-Chloro-2-hydroxynaphthalene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-Chlor-2-hydroxy-naphthalin Use and application,8-Chlor-2-hydroxy-naphthalin technical grade,usp/ep/jp grade.
Related News: According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates. 8-CHLORO-2-NAPHTHALENOL manufacturer According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates. 8-CHLORO-2-NAPHTHALENOL supplier Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs. 8-CHLORO-2-NAPHTHALENOL vendor According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates. 8-CHLORO-2-NAPHTHALENOL factory Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.
